175 related articles for article (PubMed ID: 10742291)
1. The effects of central aromatic amino acid DOPA decarboxylase inhibition on the motor actions of L-DOPA and dopamine agonists in MPTP-treated primates.
Treseder SA; Jackson M; Jenner P
Br J Pharmacol; 2000 Apr; 129(7):1355-64. PubMed ID: 10742291
[TBL] [Abstract][Full Text] [Related]
2. The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats.
Treseder SA; Rose S; Jenner P
Eur J Neurosci; 2001 Jan; 13(1):162-70. PubMed ID: 11135014
[TBL] [Abstract][Full Text] [Related]
3. Endogenous dopaminergic tone and dopamine agonist action.
Treseder SA; Smith LA; Jenner P
Mov Disord; 2000 Sep; 15(5):804-12. PubMed ID: 11009183
[TBL] [Abstract][Full Text] [Related]
4. Actions of the D1 agonists A-77636 and A-86929 on locomotion and dyskinesia in MPTP-treated L-dopa-primed common marmosets.
Pearce RK; Jackson M; Britton DR; Shiosaki K; Jenner P; Marsden CD
Psychopharmacology (Berl); 1999 Feb; 142(1):51-60. PubMed ID: 10102782
[TBL] [Abstract][Full Text] [Related]
5. Dual effects of L-3,4-dihydroxyphenylalanine on aromatic L-amino acid decarboxylase, dopamine release and motor stimulation in the reserpine-treated rat: evidence that behaviour is dopamine independent.
Fisher A; Biggs CS; Eradiri O; Starr MS
Neuroscience; 2000; 95(1):97-111. PubMed ID: 10619466
[TBL] [Abstract][Full Text] [Related]
6. In vivo antagonism of the behavioral responses to L-3-,4-dihydroxyphenylalanine by L-3-,4-dihydroxyphenylalanine cyclohexyl ester in conscious rats.
Matsushita N; Misu Y; Goshima Y
Eur J Pharmacol; 2009 Mar; 605(1-3):109-13. PubMed ID: 19168057
[TBL] [Abstract][Full Text] [Related]
7. Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to MPTP-treated common marmosets.
Löschmann PA; Smith LA; Lange KW; Jähnig P; Jenner P; Marsden CD
Psychopharmacology (Berl); 1992; 109(1-2):49-56. PubMed ID: 1365671
[TBL] [Abstract][Full Text] [Related]
8. The administration of entacapone prevents L-dopa-induced dyskinesia when added to dopamine agonist therapy in MPTP-treated primates.
Zubair M; Jackson MJ; Tayarani-Binazir K; Stockwell KA; Smith LA; Rose S; Olanow W; Jenner P
Exp Neurol; 2007 Dec; 208(2):177-84. PubMed ID: 17935716
[TBL] [Abstract][Full Text] [Related]
9. The timing of administration, dose dependence and efficacy of dopa decarboxylase inhibitors on the reversal of motor disability produced by L-DOPA in the MPTP-treated common marmoset.
Tayarani-Binazir KA; Jackson MJ; Fisher R; Zoubiane G; Rose S; Jenner P
Eur J Pharmacol; 2010 Jun; 635(1-3):109-16. PubMed ID: 20303948
[TBL] [Abstract][Full Text] [Related]
10. Combined use of the adenosine A(2A) antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys.
Kanda T; Jackson MJ; Smith LA; Pearce RK; Nakamura J; Kase H; Kuwana Y; Jenner P
Exp Neurol; 2000 Apr; 162(2):321-7. PubMed ID: 10739638
[TBL] [Abstract][Full Text] [Related]
11. Locomotor response to L-DOPA in reserpine-treated rats following central inhibition of aromatic L-amino acid decarboxylase: further evidence for non-dopaminergic actions of L-DOPA and its metabolites.
Alachkar A; Brotchie JM; Jones OT
Neurosci Res; 2010 Sep; 68(1):44-50. PubMed ID: 20542064
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of l-dopa-induced dyskinesia by switching to ropinirole in MPTP-treated common marmosets.
Jackson MJ; Smith LA; Al-Barghouthy G; Rose S; Jenner P
Exp Neurol; 2007 Mar; 204(1):162-70. PubMed ID: 17113078
[TBL] [Abstract][Full Text] [Related]
13. 3,4-methylenedioxymethamphetamine (ecstasy) inhibits dyskinesia expression and normalizes motor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates.
Iravani MM; Jackson MJ; Kuoppamäki M; Smith LA; Jenner P
J Neurosci; 2003 Oct; 23(27):9107-15. PubMed ID: 14534244
[TBL] [Abstract][Full Text] [Related]
14. The monoamine reuptake inhibitor BTS 74 398 fails to evoke established dyskinesia but does not synergise with levodopa in MPTP-treated primates.
Hansard MJ; Smith LA; Jackson MJ; Cheetham SC; Jenner P
Mov Disord; 2004 Jan; 19(1):15-21. PubMed ID: 14743355
[TBL] [Abstract][Full Text] [Related]
15. Both short- and long-acting D-1/D-2 dopamine agonists induce less dyskinesia than L-DOPA in the MPTP-lesioned common marmoset (Callithrix jacchus).
Maratos EC; Jackson MJ; Pearce RK; Cannizzaro C; Jenner P
Exp Neurol; 2003 Jan; 179(1):90-102. PubMed ID: 12504871
[TBL] [Abstract][Full Text] [Related]
16. Non-effective dose of exogenously applied L-dopa itself stereoselectively potentiates postsynaptic D2 receptor-mediated locomotor activities of conscious rats.
Nakamura S; Yue JL; Goshima Y; Miyamae T; Ueda H; Misu Y
Neurosci Lett; 1994 Mar; 170(1):22-6. PubMed ID: 7913743
[TBL] [Abstract][Full Text] [Related]
17. The dopamine D(2) receptor partial agonist aplindore improves motor deficits in MPTP-treated common marmosets alone and combined with L-dopa.
Jackson MJ; Andree TH; Hansard M; Hoffman DC; Hurtt MR; Kehne JH; Pitler TA; Smith LA; Stack G; Jenner P
J Neural Transm (Vienna); 2010 Jan; 117(1):55-67. PubMed ID: 19809864
[TBL] [Abstract][Full Text] [Related]
18. The partial dopamine agonist pardoprunox (SLV308) administered in combination with l-dopa improves efficacy and decreases dyskinesia in MPTP treated common marmosets.
Tayarani-Binazir K; Jackson MJ; Rose S; McCreary AC; Jenner P
Exp Neurol; 2010 Dec; 226(2):320-7. PubMed ID: 20843474
[TBL] [Abstract][Full Text] [Related]
19. In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates, the selective 5-hydroxytryptamine 1a agonist (R)-(+)-8-OHDPAT inhibits levodopa-induced dyskinesia but only with\ increased motor disability.
Iravani MM; Tayarani-Binazir K; Chu WB; Jackson MJ; Jenner P
J Pharmacol Exp Ther; 2006 Dec; 319(3):1225-34. PubMed ID: 16959959
[TBL] [Abstract][Full Text] [Related]
20. The adenosine A2A receptor antagonist, istradefylline enhances the anti-parkinsonian activity of low doses of dopamine agonists in MPTP-treated common marmosets.
Uchida S; Soshiroda K; Okita E; Kawai-Uchida M; Mori A; Jenner P; Kanda T
Eur J Pharmacol; 2015 Jan; 747():160-5. PubMed ID: 25499739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
